HEALTH● LOW1h ago · Sep 18, 2026, 6:55 PM
Lilly wins full FDA approval for Inluriyo combo in breast cancer
Seeking Alpha Tech · north america
Lilly has received full FDA approval for its Inluriyo combination therapy for breast cancer. This approval marks a significant development in medical treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH35m agoThe first mRNA flu shot is now available. Here’s who can get it.NBC NewsHEALTH1h agoTwo more women die in Rajasthan after C-sections; probe committee formedThe HinduHEALTH1h agoArmy’s H2F program linked to faster injury recovery among soldiers, study findsMilitary TimesHEALTH1h agoDan Buettner, longevity expert: "One of the best things you can do to add years to your life is to have a dog"Clarín